FI59813C - Foerfarande foer framstaellning av antibiotikumet ps-5 och salter daerav med en beta-laktamas inhiberande aktivitet - Google Patents

Foerfarande foer framstaellning av antibiotikumet ps-5 och salter daerav med en beta-laktamas inhiberande aktivitet Download PDF

Info

Publication number
FI59813C
FI59813C FI780671A FI780671A FI59813C FI 59813 C FI59813 C FI 59813C FI 780671 A FI780671 A FI 780671A FI 780671 A FI780671 A FI 780671A FI 59813 C FI59813 C FI 59813C
Authority
FI
Finland
Prior art keywords
antibiotic
yellow
medium
activity
light
Prior art date
Application number
FI780671A
Other languages
English (en)
Finnish (fi)
Other versions
FI780671A (fi
FI59813B (fi
Inventor
Kazuhiko Okumura
Shoji Hirata
Yasushi Okumura
Yasuo Fukagawa
Yasutaka Shimauchi
Tomoyuki Ishikura
Kageaki Kouno
Joseph Lein
Original Assignee
Panlabs Inc
Sanraku Ocean Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP52035375A external-priority patent/JPS604719B2/ja
Priority claimed from JP9465177A external-priority patent/JPS5430195A/ja
Application filed by Panlabs Inc, Sanraku Ocean Co filed Critical Panlabs Inc
Publication of FI780671A publication Critical patent/FI780671A/fi
Priority to FI801352A priority Critical patent/FI801352A/fi
Publication of FI59813B publication Critical patent/FI59813B/fi
Application granted granted Critical
Publication of FI59813C publication Critical patent/FI59813C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cephalosporin Compounds (AREA)
FI780671A 1977-03-31 1978-02-28 Foerfarande foer framstaellning av antibiotikumet ps-5 och salter daerav med en beta-laktamas inhiberande aktivitet FI59813C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI801352A FI801352A (fi) 1977-03-31 1980-04-28 Foerfarande foer framstaellning av estrar av antibioten ps-5

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP52035375A JPS604719B2 (ja) 1977-03-31 1977-03-31 β‐ラクタマーゼ阻害活性を有する抗生物質ＰＳ―５の製造方法
JP3537577 1977-03-31
JP9465177 1977-08-09
JP9465177A JPS5430195A (en) 1977-08-09 1977-08-09 Antibiotic substance ps-5 having beta-lactamase inhibiting activity, its derivative and their preparation

Publications (3)

Publication Number Publication Date
FI780671A FI780671A (fi) 1978-10-01
FI59813B FI59813B (fi) 1981-06-30
FI59813C true FI59813C (fi) 1981-10-12

Family

ID=26374352

Family Applications (1)

Application Number Title Priority Date Filing Date
FI780671A FI59813C (fi) 1977-03-31 1978-02-28 Foerfarande foer framstaellning av antibiotikumet ps-5 och salter daerav med en beta-laktamas inhiberande aktivitet

Country Status (21)

Country Link
US (1) US4318916A (fr)
AR (1) AR219738A1 (fr)
AT (1) AT362059B (fr)
AU (1) AU518781B2 (fr)
CA (1) CA1123767A (fr)
CH (1) CH643262A5 (fr)
DE (1) DE2813922A1 (fr)
DK (1) DK144098C (fr)
FI (1) FI59813C (fr)
FR (1) FR2408608B1 (fr)
GB (1) GB1598062A (fr)
GR (1) GR62185B (fr)
IE (1) IE46369B1 (fr)
IL (1) IL54118A (fr)
IT (1) IT1113066B (fr)
LU (1) LU79351A1 (fr)
NL (1) NL7802976A (fr)
NO (1) NO781076L (fr)
NZ (1) NZ186830A (fr)
PT (1) PT67848B (fr)
SE (1) SE7803623L (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0011173B1 (fr) 1978-11-01 1983-05-11 Sanraku-Ocean Co., Ltd. Procédé pour la production de composés antibiotiques bêta-lactame
DE3146190A1 (de) * 1981-11-21 1983-06-16 Hoechst Ag, 6230 Frankfurt Isolierung von chemisch instabilen antibiotika aus fermentationsloesungen
US5650290A (en) * 1994-04-01 1997-07-22 Hach Company Method & Medium for use in detecting E. coli and total coliforms
US5849515A (en) * 1994-04-01 1998-12-15 Hach Company Method and medium for use in detecting E. coli and total coliforms
KR100379075B1 (en) * 2002-03-07 2003-04-08 Jinis Biopharmaceuticals Co Method for producing low cholesterol animal food product and food product therefrom
FI20205368A1 (en) * 2020-04-07 2021-10-08 Aalto Univ Foundation Sr FORMULATION
CN111826334A (zh) * 2020-07-24 2020-10-27 暨南大学 一种超长大肠杆菌及其制备方法与应用
CN113960188B (zh) * 2021-09-09 2024-01-26 中车青岛四方机车车辆股份有限公司 高效液相色谱-串联质谱法测定样品中的4,4-二(二甲氨基)-4-甲氨基三苯甲醇

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928569A (en) * 1972-08-09 1975-12-23 Microbial Chem Res Found Two substances inhibiting beta-lactamase and their production
GB1467413A (en) * 1974-03-28 1977-03-16 Beecham Group Ltd Antibiotics
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics
US4165379A (en) * 1975-11-21 1979-08-21 Merck & Co., Inc. N-acetyl thienamycin
US4162324A (en) * 1975-11-21 1979-07-24 Merck & Co., Inc. Antibiotics 890A1 and 890A3
NL7704040A (nl) * 1976-04-28 1977-11-01 Merck & Co Inc Werkwijze voor het bereiden van nieuwe anti- biotica.
NL7802826A (nl) * 1977-04-08 1978-10-10 Merck & Co Inc Thienamycinederivaat, werkwijze voor het bereiden daarvan, alsmede farmaceutische preparaten.
US4162323A (en) * 1977-04-18 1979-07-24 Merck & Co., Inc. Antibiotic N-acetyl-dehydro-thienamycin
US4235922A (en) * 1979-06-15 1980-11-25 Merck & Co., Inc. 3-(2-Aminoethylthio)-6-ethyl-7-oxo-1-azabicyclo [3.2.0]hept-2-ene-2-carboxylic acid

Also Published As

Publication number Publication date
IE46369B1 (en) 1983-05-18
US4318916A (en) 1982-03-09
FR2408608A1 (fr) 1979-06-08
IT7821748A0 (it) 1978-03-30
IE780638L (en) 1978-09-30
GR62185B (en) 1979-03-02
IT1113066B (it) 1986-01-20
SE7803623L (sv) 1978-11-17
DE2813922A1 (de) 1978-10-19
PT67848A (en) 1978-04-01
AU518781B2 (en) 1981-10-22
NL7802976A (nl) 1978-10-03
DK144098C (da) 1982-06-01
DK144098B (da) 1981-12-07
AR219738A1 (es) 1980-09-15
DK143678A (da) 1978-10-01
FI780671A (fi) 1978-10-01
NO781076L (no) 1978-10-03
IL54118A (en) 1981-09-13
LU79351A1 (fr) 1979-03-26
FI59813B (fi) 1981-06-30
PT67848B (en) 1979-09-28
AU3459278A (en) 1979-10-04
GB1598062A (en) 1981-09-16
AT362059B (de) 1981-04-27
ATA224578A (de) 1980-09-15
CA1123767A (fr) 1982-05-18
NZ186830A (en) 1981-12-15
FR2408608B1 (fr) 1986-05-16
CH643262A5 (de) 1984-05-30

Similar Documents

Publication Publication Date Title
Stapley et al. Cephamycins, a new family of β-lactam antibiotics I. Production by Actinomycetes, including Streptomyces lactamdurans sp. n
EP0376300B1 (fr) Substance DC 113 et procédé pour sa production
Okamura et al. PS-5, a new β-lactam antibiotic from Streptomyces
US4530835A (en) CL-1577 Antibiotic compounds and their production
CA1242159A (fr) Bbm-2478, complexe antibiotique
Okamura et al. PS-5, A NEW β-LACTAM ANTIBIOTIC. I TAXONOMY OF THE PRODUCING ORGANISM, ISOLATION AND PHYSICO-CHEMICAL PROPERTIES
FI59813C (fi) Foerfarande foer framstaellning av antibiotikumet ps-5 och salter daerav med en beta-laktamas inhiberande aktivitet
EP1211259B1 (fr) Caprazamycines antibiotiques et leur procede de production
CA1213542A (fr) Antibiotique bbm-2040 antitumoral produit par les streptomyces
Okabe et al. STUDIES ON THE OA-6129 GROUP OF ANTIBIOTICS, NEW CARBAPENEM COMPOUNDS I. TAXONOMY, ISOLATION AND PHYSICAL PROPERTIES
US4368203A (en) Antibiotics and derivatives thereof having β-lactamase inhibitory activity and production thereof
SHIBAMAMOTO et al. PS-8, a minor carbapenem antibiotic
US4806566A (en) Anti-gram positive bacteria tri-yne carbonates
CA1159782A (fr) Pa-39504-x inn nn antibiotique et mode de production
US4861796A (en) Gentisic acid derivatives having antibiotic activity
US5334613A (en) Antibacterial substance BE-24566B
US4427655A (en) Antibiotics-875A and production thereof
EP0436935A1 (fr) Alisamycine, nouvel antibiotique, son procédé de production et son utilisation
US4100273A (en) Antibiotic substance from Actinoplanes sarveparensis CBS 305.76 (antibiotic L 13365)
EP0002058B1 (fr) 3-(2-Aminoéthylthio-6-éthyl-7-oxo-1-azabicylo-(3.2.0)-hept-2-en-2-acide carboxylique, procédé pour sa préparation et compositions le contenant
US4468350A (en) KA-6643-Series antibiotics, process for producing same and medical composition containing same
IWAMI et al. NEW ANTITUMOR ANTIBIOTIC, FR-900462 II. PRODUCTION, ISOLATION, CHARACTERIZATION AND BIOLOGICAL ACTIVITY
US5162368A (en) Butalactin and its use as pharmaceutical
Bombay et al. EUROPEAN PATENT APPLICATION
JPS6215558B2 (fr)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SANRAKU-OCEAN CO., LTD.

Owner name: PANLABS INC